carbapenems

carbapenems are often considered the last line of defense against multidrug-resistant gram-negative bacterial infections.

doctors prescribe carbapenems when other antibiotics have failed to treat severe hospital-acquired infections.

the increasing prevalence of carbapenem-resistant enterobacteriaceae poses a significant threat to global public health.

meropenem and imipenem are among the most commonly used carbapenems in clinical practice today.

patients with a documented penicillin allergy may require careful monitoring when receiving carbapenems.

microbiology labs perform specific tests to detect the presence of carbapenemase production in bacterial isolates.

the pharmacist reviewed the appropriate dosing of carbapenems for patients with renal impairment.

carbapenems exhibit stability against a wide variety of beta-lactamase enzymes produced by resistant bacteria.

inappropriate overuse of carbapenems has accelerated the development of resistance in healthcare settings.

ertapenem is a unique carbapenem that can be administered once daily due to its long half-life.

combination therapy is frequently necessary to treat infections caused by carbapenem-resistant organisms.

the hospital formulary committee placed restrictions on carbapenems to preserve their efficacy.